Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ANI Pharmaceuticals, Inc. ANIP

Full chart Compare
Set alert

Price alert · ANIP

All alert types
69.62 USD -2.03 (-2.83%)

At closeNov 5, 2026, 4:00 PM EST

69.62 0.00 0.00%

After hours · Nov 5, 4:00 PM ET

68.79 Day range 76.00
68.79 52-week range 95.45
YTD
-11.81%
1 year
-24.83%

Financial health

Altman Z-Score

2.59 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B+3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 4
  • Debt / Equity 2
  • P/E 3
  • P/B 3

Valuation

P/E 22.6×
FY 2016: 178×FY 2017: -692×FY 2018: 33.8×FY 2019: 121×FY 2020: -15.4×FY 2021: -13.6×FY 2022: -13.2×FY 2023: 58.0×FY 2024: -53.2×FY 2025: 22.6×
FY 2016 5y median -13.2× FY 2025
P/S 1.8×
FY 2016: 5.4×FY 2017: 4.2×FY 2018: 2.6×FY 2019: 3.5×FY 2020: 1.7×FY 2021: 2.7×FY 2022: 2.1×FY 2023: 2.0×FY 2024: 1.7×FY 2025: 1.8×
FY 2016 5y median 2.0× FY 2025
P/B 2.9×
FY 2016: 4.1×FY 2017: 4.3×FY 2018: 2.7×FY 2019: 3.4×FY 2020: 1.8×FY 2021: 1.6×FY 2022: 1.9×FY 2023: 2.2×FY 2024: 2.5×FY 2025: 2.9×
FY 2016 5y median 2.2× FY 2025
P/FCF 10.5×
FY 2016: -5.7×FY 2017: -10.9×FY 2018: 9.4×FY 2019: 40.4×FY 2020: -6.5×FY 2021: -28.6×FY 2022: -13.7×FY 2023: 9.9×FY 2024: 22.7×FY 2025: 10.5×
FY 2016 5y median 9.9× FY 2025
EV/EBITDA 7.8×
FY 2016: 14.0×FY 2017: 16.0×FY 2018: 9.6×FY 2019: 14.1×FY 2020: 18.7×FY 2021: 246×FY 2022: 35.6×FY 2023: 9.9×FY 2024: 24.5×FY 2025: 7.8×
FY 2016 5y median 24.5× FY 2025
EV/Sales 1.8×
FY 2016: 6.1×FY 2017: 5.2×FY 2018: 3.3×FY 2019: 4.1×FY 2020: 2.5×FY 2021: 3.6×FY 2022: 2.8×FY 2023: 2.2×FY 2024: 2.5×FY 2025: 1.8×
FY 2016 5y median 2.5× FY 2025
FCF Yield 9.5%
FY 2016: -17.5%FY 2017: -9.2%FY 2018: 10.7%FY 2019: 2.5%FY 2020: -15.3%FY 2021: -3.5%FY 2022: -7.3%FY 2023: 10.1%FY 2024: 4.4%FY 2025: 9.5%
FY 2016 5y median 4.4% FY 2025

Profitability

Gross Margin 51.0%
FY 2016: 62.1%FY 2017: 55.3%FY 2018: 63.8%FY 2019: 69.4%FY 2020: 58.2%FY 2021: 53.5%FY 2022: 56.1%FY 2023: 62.7%FY 2024: 59.3%FY 2025: 51.0%
FY 2016 5y median 56.1% FY 2025
Operating Margin 9.2%
FY 2016: 15.6%FY 2017: 16.0%FY 2018: 17.5%FY 2019: 7.9%FY 2020: -7.7%FY 2021: -18.4%FY 2022: -11.2%FY 2023: 9.6%FY 2024: 0.1%FY 2025: 9.2%
FY 2016 5y median 0.1% FY 2025
Net Margin 8.9%
FY 2016: 3.1%FY 2017: -0.6%FY 2018: 7.7%FY 2019: 3.0%FY 2020: -10.8%FY 2021: -19.7%FY 2022: -15.1%FY 2023: 3.9%FY 2024: -3.0%FY 2025: 8.9%
FY 2016 5y median -3.0% FY 2025
ROE 14.5%
FY 2016: 2.3%FY 2017: -0.6%FY 2018: 7.9%FY 2019: 2.9%FY 2020: -11.5%FY 2021: -11.9%FY 2022: -14.1%FY 2023: 4.1%FY 2024: -4.3%FY 2025: 14.5%
FY 2016 5y median -4.3% FY 2025
ROIC 5.6%
FY 2016: 3.1%FY 2017: -0.5%FY 2018: 7.2%FY 2019: 4.0%FY 2020: -3.5%FY 2021: -4.4%FY 2022: -4.1%FY 2023: 5.8%FY 2024: 0.0%FY 2025: 5.6%
FY 2016 5y median 0.0% FY 2025
ROA 5.4%
FY 2016: 1.2%FY 2017: -0.3%FY 2018: 3.6%FY 2019: 1.3%FY 2020: -4.9%FY 2021: -5.5%FY 2022: -6.3%FY 2023: 2.1%FY 2024: -1.4%FY 2025: 5.4%
FY 2016 5y median -1.4% FY 2025

Growth (YoY)

Revenue 43.8%
FY 2016: 68.5%FY 2017: 37.5%FY 2018: 14.0%FY 2019: 2.5%FY 2020: 0.9%FY 2021: 3.7%FY 2022: 46.4%FY 2023: 53.9%FY 2024: 26.2%FY 2025: 43.8%
FY 2016 FY 2025
Operating Income 13809.2%
FY 2016: -38.6%FY 2017: 41.1%FY 2018: 24.8%FY 2019: -53.8%FY 2020: -198.0%FY 2021: -148.5%FY 2022: 11.3%FY 2023: 233.1%FY 2024: -98.8%FY 2025: 13809.2%
FY 2016 FY 2025
EPS (diluted) 419.2%
FY 2016: -74.2%FY 2017: -127.4%FY 2018: 1516.3%FY 2019: -62.1%FY 2020: -476.0%FY 2021: -80.9%FY 2022: 10.3%FY 2023: 130.8%FY 2024: -210.6%FY 2025: 419.2%
FY 2016 FY 2025
Free Cash Flow 220.6%
FY 2016: -688.6%FY 2017: 43.6%FY 2018: 181.9%FY 2019: -67.8%FY 2020: -393.4%FY 2021: 61.7%FY 2022: -134.6%FY 2023: 310.8%FY 2024: -53.1%FY 2025: 220.6%
FY 2016 FY 2025

Financial Health

Current Ratio 2.7×
FY 2016: 3.2×FY 2017: 3.4×FY 2018: 0.9×FY 2019: 3.0×FY 2020: 2.2×FY 2021: 3.7×FY 2022: 3.5×FY 2023: 3.6×FY 2024: 2.7×FY 2025: 2.7×
FY 2016 5y median 3.5× FY 2025
Quick Ratio 2.2×
FY 2016: 2.4×FY 2017: 2.4×FY 2018: 0.7×FY 2019: 2.3×FY 2020: 1.4×FY 2021: 2.7×FY 2022: 2.4×FY 2023: 2.8×FY 2024: 2.0×FY 2025: 2.2×
FY 2016 5y median 2.4× FY 2025
Debt / Equity 0.6×
FY 2016: 0.7×FY 2017: 1.2×FY 2018: 0.9×FY 2019: 0.9×FY 2020: 0.9×FY 2021: 0.8×FY 2022: 0.8×FY 2023: 0.6×FY 2024: 1.5×FY 2025: 0.6×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 1.7×FY 2017: 3.0×FY 2018: 2.0×FY 2019: 2.0×FY 2020: 6.3×FY 2021: 60.0×FY 2022: 9.5×FY 2023: 0.6×FY 2024: 7.6×FY 2025: 0.2×
FY 2016 5y median 7.6× FY 2025
Interest Coverage 4.0×
FY 2016: 1.8×FY 2017: 2.4×FY 2018: 2.4×FY 2019: 1.3×FY 2020: -1.7×FY 2021: -3.3×FY 2022: -1.3×FY 2023: 1.7×FY 2024: 0.0×FY 2025: 4.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.2%FY 2023: 0.2%FY 2024: 0.2%FY 2025: 0.1%
FY 2016 5y median 0.2% FY 2025
Payout Ratio 1.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -0.4%FY 2022: -3.4%FY 2023: 8.7%FY 2024: -8.8%FY 2025: 1.5%
FY 2016 5y median -0.4% FY 2025

Annual · latest fiscal year ends 2025-12-31